Introduction: Chongqing Winbond Pharmaceutical Co., Ltd. is one of the core pharmaceutical companies of Winbond Life and Health Co., Ltd. (Shenzhen code 002004), headquartered in Chongqing. The company's preparations and bulk drug products are sold to domestic and foreign markets, and have made remarkable progress in the fields of skin, tuberculosis and other therapeutic drugs, and have been in the leading position in domestic skin clinical drugs for many years. Chongqing Winbond Pharmaceutical Co., Ltd. has made remarkable progress in the field of skin, tuberculosis and other therapeutic drugs, and has been in the leading position of domestic skin clinical drugs for many years. The main products are Avia capsules, viaminate capsules, isotretinoin soft capsules, compound aminopeptide tablets, tazarotene gel/cream, tretinoin cream, viaminate cream, desonide cream, hydrocortisone butyrate cream, betamethasone dipropionate cream, naftifine ketoconazole cream, bifonazole gel, triamcinolone acetonide econazole cream, penciclovir cream, levocetirizine hydrochloride tablets and levocetirizine hydrochloride oral. In 2007, the company was recognized as a national key high-tech enterprise by the Ministry of Science and Technology. The proof material comes from Xinhuanet, which was awarded the "National May 1st Labor Award" by the All-China Federation of Trade Unions in April 2003. The proof material comes from xinhuanet.
Legal representative: Lu Liming.
Establishment time: 20 12-06-26
Registered capital: RMB 450 million.
Industrial and commercial registration number: 500000010378
Type of enterprise: limited liability company (wholly owned by legal person)
Company Address: No.69 Renhe Avenue of Stars, Yubei District, Chongqing